ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #1,040Top JournalGold OA

Neurology-Neuroimmunology & Neuroinflammation

Acronym:nxi
•
Abbreviation (ISO):NEUROL-NEUROIMMUNOL
•
Identifier (ISSN):2332-7812(Print)
•
Publisher:Lippincott Williams and Wilkins Ltd.
Clarivate IF (2026)
8↑ +0.5
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Neurology-Neuroimmunology & Neuroinflammation

WoS Q1
051015020187.3520197.7220208.48202111.420228.820237.820247.5202582026
Annual Impact Factor Metric
Current (2026):8
Scopus SJR & RankScopus Q1
2.4
#1,040

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
86

86 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate3.8%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
152articles/year
100% Gold OA•91.67% Original Research

Aims & Scope

Neurology: Neuroimmunology & NeuroInflammation is an official journal of the American Academy of Neurology. Vision: Our vision is to be the premier peer-reviewed journal for experts in the fields of neuroimmunology and neuroinflammation. Mission: The mission of Neurology Neuroimmunology & Neuroinflammation is to provide neurologists and translationally minded scientists with peer-reviewed articles, editorials, and reviews to enhance patient care, education, and clinical & translational research. We publish rigorously peer-reviewed open access reports of original research and in-depth reviews of topics in neuroimmunology & neuroinflammation, affecting the full range of neurologic diseases including (but not limited to): Alzheimer disease, Parkinson disease, ALS, tauopathy, and stroke; multiple sclerosis and NMO; inflammatory peripheral nerve and muscle disease, Guillain-Barré and myasthenia; nervous system infection; paraneoplastic syndromes, noninfectious encephalitides and other antibody-mediated disorders; and psychiatric and neurodevelopmental disorders. Clinical trials, instructive case reports, and small case series will also be featured.

Topics Covered (Recognized by AI)
Medicine90.1%Biology86.2%Internal medicine79.3%Immunology75%Psychology67.8%Pathology67.3%Genetics67.1%Psychiatry61.9%Multiple sclerosis39.1%Antibody37.6%Neuroscience36.3%Disease36.3%Chemistry34.4%Biochemistry32.3%Surgery30.3%Endocrinology26%Immune system23%Virology21%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

CLINICAL NEUROLOGY

Q1
Rank17/296
IndexSCIE
JCRSCIE2026

NEUROSCIENCES

Q1
Rank27/330
IndexSCIE
JCISCIE2026

CLINICAL NEUROLOGY

Q1
Rank12/296
IndexSCIE
JCISCIE2026

NEUROSCIENCES

Q1
Rank14/330
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF8
Articles / Year89
Total Citations70
2025
IF7.5
Articles / Year149
Total Citations795
2024
IF7.8
Articles / Year154
Total Citations1,787
2023
IF8.8
Articles / Year116
Total Citations2,270
2022
IF11.36
Articles / Year130
Total Citations4,296

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #1,040Scopus Q1SCImago Profile
Scopus Coverage:2014-2026
Scopus Broad Areas:MedicineNeuroscience
Scopus Citation Rank (SJR)Q1
2.4

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
6.27

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,960 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations2,657
3-Year Documents397
Citable Documents387

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate47.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

NeurologyQ1
Neurology (clinical)Q1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 3.8%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
1区 (Zone 1)Medicine
Minor Category (Specific Field):
1区CLINICAL NEUROLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Neurology-Neuroimmunology & Neuroinflammation (acronym: nxi, abbr: NEUROL-NEUROIMMUNOL, ISSN: 2332-7812) is a peer-reviewed international scholarly journal in the field of Neuroscience, published by Lippincott Williams and Wilkins Ltd. in United States. The periodical holds a Journal Impact Factor (JIF) of 8.00, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 2.400 (Q1), an H-index of 86.

The journal enforces rigorous peer evaluation with an annual output of approximately 152 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,960 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Gold OA
Publisher
Lippincott Williams and Wilkins Ltd.
Publication Language
English
Frequency
Periodic
Indexing & Databases
SCIEScopusDOAJPubMed
Editorial Address
TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, USA, PA, 19103

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: f56dcaab-3b93-417c-8aee-587458398f4d
Database Updated: 2026-10-01